EC50 (95% CI) | Maximum | N | |
---|---|---|---|
μM | % | ||
WT GluN2C | 16 (15, 17) | 257 ± 3.8 | 20 |
GluN2C-W162F | N.D. | N.D. | 9 |
GluN2C-S163Y | 25 (24, 26)* | 280 ± 8.1 | 10 |
GluN2C-R194I | 21 (20, 23)* | 250 ± 3.0 | 9 |
GluN2C-R194K | 8.0 (7, 9)* | 246 ± 5.0 | 8 |
GluN2C-D220R | N.D. | N.D. | 14 |
GluN2C-G249D | 13 (11, 15)* | 200 ± 3.6 | 10 |
GluN2C-G425F | 18 (17, 19) | 252 ± 6.7 | 11 |
GluN2C-V431F | 36 (34, 39)* | 258 ± 9.1 | 9 |
GluN2C-Y473F | 34 (32, 36)* | 258 ± 5.0 | 12 |
GluN2C-Y473I | 39 (29, 47)* | 228 ± 9.5 | 8 |
↵* P < 0.05 for log EC50 values compared with same day controls (ANOVA, Bonferroni post-hoc test; F8,86 = 97.14). Power to detect an effect size of 0.5 was 0.94.
Concentration-effect curves for PYD-106 were generated for GluN2C mutations and fitted by the Hill equation (see Materials and Methods). The mean EC50 and mean fitted maximum response as a percent of control (95% CI determined from log EC50) are given. N is the number of oocytes, which were isolated from two to four different frogs. N.D., the EC50 could not be determined because either there was no effect of PYD-106 or the maximal potentiation was not obtained in the concentration range tested.